Navigation Links
Caliper Life Sciences Collaborates with University of Miami to Automate Next Generation Sequencing Workflows
Date:2/3/2011

HOPKINTON, Mass., Feb. 3, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced a collaboration with the John P. Hussman Institute for Human Genomics (HIHG) at the University of Miami. As part of this agreement, HIHG is working with Caliper to develop automated protocols for exome capture and library preparation workflows.  HIHG has been an early access partner for the recently released high sensitivity assay for Caliper's LabChip® GX platform.

"At HIHG, we conduct genetic studies that contribute to the better understanding of inherited genetic diseases and disorders," said John Gilbert, PhD, Professor and Director of the Center for Genome Technology at the HIHG. "With our recent implementation of higher capacity sequencing technologies, and our focus on exome sequencing projects, sample preparation has become a bottleneck. We are actively working with Caliper to automate multiple steps of this process and increase our overall sequencing throughput."

"The research being conducted at HIHG is extraordinary and will significantly expand the molecular understanding of disease," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "Caliper is excited to collaborate with the HIHG to enable higher throughput exome sequencing."

Details of this collaboration will be presented at the Advances in Genome Biology and Technology conference taking place from February 2-5 in Marco Island, Florida. For a complete list of presentations taking place at AGBT, please visit http://agbt.org/agenda.html.

About Hussman Institute for Human Genomics at the University of Miami

The John P. Hussman Institute for Human Genomics (HIHG) was established at the University of Miami Miller School of Medicine in January 2007 to discover the genetic influences on human health and apply this knowledge to the practice of medicine through improved diagnostics, treatments, and medications, thus translating the unprecedented scientific advance of the "Human Genome Project" into information that can benefit patients directly. The Institute is committed to collaborative pan-institutional initiatives, ensuring that resources, skills, and ideas forthcoming from novel genetic and genomic approaches will be made available to the entire medical community.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper, LabChip, Zephyr and Sciclone are registered trademarks of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences Launches Microfluidic LabChip® DS Platform for UV/VIS Spectral Analysis of Nucleic Acid and Protein Samples
2. NuGEN and Caliper Partner to Eliminate Next-Gen Sequencing Sample Preparation Bottlenecks
3. Caliper Life Sciences Announces Preliminary Results for the Fourth Quarter and 2010
4. Caliper Life Sciences CEO to Present Keynote Presentation at MipTec European Conference
5. Caliper Life Sciences to Present at UBS 2010 Global Life Sciences Conference
6. Caliper Life Sciences Second Quarter 2010 Financial Results Conference Call Notice
7. Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life
8. Caliper Life Sciences to Webcast Investor Session of Open House
9. Caliper Life Sciences to Present at Jefferies 2010 Global Life Sciences Conference
10. Caliper Enhances Strategic Focus and Increases Growth Capital with Sale of Product Lines to Biotage
11. Caliper Awarded Additional Task Order for EPA ToxCast Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... ... Safety Technology Consortium™ (SafeTEC™), $3 million in investment towards 15+ TEC Validation Projects™. ... and assays, and their applicability in drug safety assessment, for the industry as ...
(Date:1/17/2017)... COLUMBUS, Ohio , Jan. 17, 2017  On ... with the 35th Annual J.P. Morgan Healthcare Conference in ... Joseph D. Kittle, Jr. , spoke to pharmaceutical ... technology developed by ProclaRx to break down and destroy ... which protect bacteria and prevent antibiotics and the body,s ...
(Date:1/16/2017)... , Jan. 16, 2017  Eurofins Genomics today announced ... allow more customers to receive their primers in a ... compromise in quality found with other providers. Express oligos ... States at no additional fee. ... genetic studies, including DNA sequencing, genotyping, site-directed mutagenesis, and ...
(Date:1/13/2017)... Research and Markets has announced the addition of the ... ... a CAGR of 16.83% during the period 2017-2021. The ... biopolymers market for 2017-2021. To calculate the market size, the report considers ... report also includes a a discussion of the key vendors operating in ...
Breaking Biology Technology:
(Date:12/15/2016)... Mich. , Dec. 15, 2016  There is ... car doors or starting the engine. Continental will demonstrate ... Las Vegas . Through the combination ... Start and Entry) and biometric elements, the international technology ... of vehicle personalization and authentication. "The integration ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at ... possibilities for graphene by combining the material with ... highly sensitive pressure detector able to sense pulse, ... a small spider.  The research ... can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/8/2016)... 2016  Singulex, Inc., the leader in Next Generation ... a license and supply agreement with Thermo Fisher Scientific, ... Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), a ... used to diagnose systemic bacterial infection and sepsis and ... aid in assessing the risk of critically ill patients ...
Breaking Biology News(10 mins):